BRCA1 carriers have earlier-onset disease, particularly under age 50 and are more likely to develop aggressive triple-negative breast cancer than BRCA2 carriers or those who are BRCA mutation negative [13]. This evidence concerns the gene BRCA1 and triple-negative breast carcinoma.